Cytotoxic effect, enzyme inhibition, and in silico studies of some novel N-substituted sulfonyl amides incorporating 1,3,4-oxadiazol structural motif
The acetylcholinesterase and carbonic anhydrase inhibitors (AChEIs and h CAIs) remain key therapeutic agents for many bioactivities such as anti-Alzheimer and antiobesity antiepileptic, anticancer, antiinfective, antiglaucoma, and diuretic effects. Here, it has been attempted to discover novel multi...
Saved in:
| Published in | Molecular diversity Vol. 26; no. 5; pp. 2825 - 2845 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Cham
Springer International Publishing
01.10.2022
Springer Nature B.V |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The acetylcholinesterase and carbonic anhydrase inhibitors (AChEIs and
h
CAIs) remain key therapeutic agents for many bioactivities such as anti-Alzheimer and antiobesity antiepileptic, anticancer, antiinfective, antiglaucoma, and diuretic effects. Here, it has been attempted to discover novel multi-target AChEIs and
h
CAIs that are highly potent, orally bioavailable, may be brain penetrant, and have higher effectiveness at lower doses than tacrine and acetazolamide. After detailed investigations both in vitro and in silico, novel
N
-substituted sulfonyl amide derivatives (
6a–j
) were determined to be highly potent inhibitors for AChE and
h
CAs (
K
I
s are in the range of 23.11–52.49 nM, 18.66–59.62 nM, and 9.33–120.80 nM for AChE,
h
CA I, and
h
CA II, respectively). Moreover, according to the cytotoxic effect studies, such as the ADME-Tox, cortex neuron cells, and neuroblastoma SH-SY5Y cell line, compounds
6a
,
6d
, and
6h
, which are the most potent representative versus the target enzymes, were identified as orally bioavailable, highly selective, and brain preferentially distributed AChEIs and
h
CAIs. The docking studies revealed precise binding modes between
6a
,
6d
, and
6h
and
h
CA II,
h
CA I, and AChE, respectively. The results presented here might provide a solid basis for further investigation into more potent AChEIs and
h
CAIs.
Graphical abstract |
|---|---|
| AbstractList | The acetylcholinesterase and carbonic anhydrase inhibitors (AChEIs and hCAIs) remain key therapeutic agents for many bioactivities such as anti-Alzheimer and antiobesity antiepileptic, anticancer, antiinfective, antiglaucoma, and diuretic effects. Here, it has been attempted to discover novel multi-target AChEIs and hCAIs that are highly potent, orally bioavailable, may be brain penetrant, and have higher effectiveness at lower doses than tacrine and acetazolamide. After detailed investigations both in vitro and in silico, novel N-substituted sulfonyl amide derivatives (6a–j) were determined to be highly potent inhibitors for AChE and hCAs (KIs are in the range of 23.11–52.49 nM, 18.66–59.62 nM, and 9.33–120.80 nM for AChE, hCA I, and hCA II, respectively). Moreover, according to the cytotoxic effect studies, such as the ADME-Tox, cortex neuron cells, and neuroblastoma SH-SY5Y cell line, compounds 6a, 6d, and 6h, which are the most potent representative versus the target enzymes, were identified as orally bioavailable, highly selective, and brain preferentially distributed AChEIs and hCAIs. The docking studies revealed precise binding modes between 6a, 6d, and 6h and hCA II, hCA I, and AChE, respectively. The results presented here might provide a solid basis for further investigation into more potent AChEIs and hCAIs. The acetylcholinesterase and carbonic anhydrase inhibitors (AChEIs and h CAIs) remain key therapeutic agents for many bioactivities such as anti-Alzheimer and antiobesity antiepileptic, anticancer, antiinfective, antiglaucoma, and diuretic effects. Here, it has been attempted to discover novel multi-target AChEIs and h CAIs that are highly potent, orally bioavailable, may be brain penetrant, and have higher effectiveness at lower doses than tacrine and acetazolamide. After detailed investigations both in vitro and in silico, novel N -substituted sulfonyl amide derivatives ( 6a–j ) were determined to be highly potent inhibitors for AChE and h CAs ( K I s are in the range of 23.11–52.49 nM, 18.66–59.62 nM, and 9.33–120.80 nM for AChE, h CA I, and h CA II, respectively). Moreover, according to the cytotoxic effect studies, such as the ADME-Tox, cortex neuron cells, and neuroblastoma SH-SY5Y cell line, compounds 6a , 6d , and 6h , which are the most potent representative versus the target enzymes, were identified as orally bioavailable, highly selective, and brain preferentially distributed AChEIs and h CAIs. The docking studies revealed precise binding modes between 6a , 6d , and 6h and h CA II, h CA I, and AChE, respectively. The results presented here might provide a solid basis for further investigation into more potent AChEIs and h CAIs. Graphical abstract The acetylcholinesterase and carbonic anhydrase inhibitors (AChEIs and hCAIs) remain key therapeutic agents for many bioactivities such as anti-Alzheimer and antiobesity antiepileptic, anticancer, antiinfective, antiglaucoma, and diuretic effects. Here, it has been attempted to discover novel multi-target AChEIs and hCAIs that are highly potent, orally bioavailable, may be brain penetrant, and have higher effectiveness at lower doses than tacrine and acetazolamide. After detailed investigations both in vitro and in silico, novel N-substituted sulfonyl amide derivatives (6a-j) were determined to be highly potent inhibitors for AChE and hCAs (K s are in the range of 23.11-52.49 nM, 18.66-59.62 nM, and 9.33-120.80 nM for AChE, hCA I, and hCA II, respectively). Moreover, according to the cytotoxic effect studies, such as the ADME-Tox, cortex neuron cells, and neuroblastoma SH-SY5Y cell line, compounds 6a, 6d, and 6h, which are the most potent representative versus the target enzymes, were identified as orally bioavailable, highly selective, and brain preferentially distributed AChEIs and hCAIs. The docking studies revealed precise binding modes between 6a, 6d, and 6h and hCA II, hCA I, and AChE, respectively. The results presented here might provide a solid basis for further investigation into more potent AChEIs and hCAIs. |
| Author | Arslan, Mustafa Güleç, Özcan Demir, Yeliz Beydemir, Şükrü Türkeş, Cüneyt Yeni, Yeşim Ereminsoy, Ergün Hacımüftüoğlu, Ahmet Küfrevioğlu, Ömer İrfan |
| Author_xml | – sequence: 1 givenname: Özcan surname: Güleç fullname: Güleç, Özcan organization: Department of Chemistry, Faculty of Arts and Science, Sakarya University – sequence: 2 givenname: Cüneyt orcidid: 0000-0002-2932-2789 surname: Türkeş fullname: Türkeş, Cüneyt email: cuneyt.turkes@erzincan.edu.tr organization: Department of Biochemistry, Faculty of Pharmacy, Erzincan Binali Yıldırım University – sequence: 3 givenname: Mustafa orcidid: 0000-0003-0796-4374 surname: Arslan fullname: Arslan, Mustafa email: marslan@sakarya.edu.tr organization: Department of Chemistry, Faculty of Arts and Science, Sakarya University – sequence: 4 givenname: Yeliz surname: Demir fullname: Demir, Yeliz organization: Department of Pharmacy Services, Nihat Delibalta Göle Vocational High School, Ardahan University – sequence: 5 givenname: Yeşim surname: Yeni fullname: Yeni, Yeşim organization: Department of Medical Pharmacology, Faculty of Medicine, Atatürk University – sequence: 6 givenname: Ahmet surname: Hacımüftüoğlu fullname: Hacımüftüoğlu, Ahmet organization: Department of Medical Pharmacology, Faculty of Medicine, Atatürk University – sequence: 7 givenname: Ergün surname: Ereminsoy fullname: Ereminsoy, Ergün organization: Department of Chemistry, Faculty of Science, Atatürk University – sequence: 8 givenname: Ömer İrfan surname: Küfrevioğlu fullname: Küfrevioğlu, Ömer İrfan organization: Department of Chemistry, Faculty of Science, Atatürk University – sequence: 9 givenname: Şükrü surname: Beydemir fullname: Beydemir, Şükrü organization: Department of Biochemistry, Faculty of Pharmacy, Anadolu University, The Rectorate of Bilecik Şeyh Edebali University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35397086$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kcluFDEQhlsoiCzwAhyQJS4cpsFlu7vdFyQ0CosUJReQuFlut3viqNs1eIkyeY-8L4YJYTlw8aL6_r-q9B9XBx69rarnQF8Dpd2bCEA5rSljNVBRTvmoOoKm43VD4etBeXMJNfQ9HFbHMV5RWmTAn1SHvOF9R2V7VN2tdwkT3jhD7DRZk1bE-tvdYonzl25wyaFfEe3H8ifRzc4giSmPzkaCE4lYSI_XdibndcxDTC7lZEcS8zyh381EL24srPMGwxaDTs5vCKz4StR4o0enb3EujiGblIOeyYLJTU-rx5Oeo312f59UX96ffl5_rM8uPnxavzurjaAi1YIbPlgJo9AceDN2Ewy6EdBr3ULXtpK2jW0YN1TzYaCM6klwwaAXcmw6afhJ9Xbvu83DYkdjfSozqG1wiw47hdqpvyveXaoNXivZ94L2ohi8ujcI-C3bmNTiorHzrL3FHBVrhSxsw2hBX_6DXmEOvqynWMeAdiUTKBTbUyZgjMFOD8MAVT9SV_vUVUld_UxdySJ68ecaD5JfMReA74FYSn5jw-_e_7H9Dp8JvFA |
| CitedBy_id | crossref_primary_10_1002_jmr_3083 crossref_primary_10_1002_cbdv_202300687 crossref_primary_10_1002_slct_202400485 crossref_primary_10_1016_j_molstruc_2023_137308 crossref_primary_10_1002_slct_202204350 crossref_primary_10_2174_1570180819666220812144409 crossref_primary_10_1016_j_fct_2022_113583 crossref_primary_10_3390_ijms232415893 crossref_primary_10_1002_bab_2532 crossref_primary_10_1002_cbdv_202301093 crossref_primary_10_1038_s41598_023_29446_7 crossref_primary_10_1080_07391102_2023_2240889 crossref_primary_10_1007_s11696_022_02511_7 crossref_primary_10_1002_ardp_202300634 crossref_primary_10_2174_1389557523666230502143131 crossref_primary_10_2174_1389557523666230627140816 crossref_primary_10_1080_17568919_2024_2359894 crossref_primary_10_1080_07391102_2023_2224887 crossref_primary_10_1007_s11030_022_10526_1 crossref_primary_10_1080_07391102_2023_2190825 crossref_primary_10_1002_slct_202300648 crossref_primary_10_1186_s12906_023_03976_z crossref_primary_10_1002_cbdv_202301063 crossref_primary_10_1016_j_molstruc_2024_139177 crossref_primary_10_1002_cbdv_202200280 crossref_primary_10_1080_07391102_2024_2331085 crossref_primary_10_2174_0113895575263108231031132404 crossref_primary_10_1002_jmr_3058 crossref_primary_10_1016_j_molstruc_2023_135077 crossref_primary_10_1016_j_molstruc_2023_137137 crossref_primary_10_1002_ardp_202200570 crossref_primary_10_1002_cbdv_202300611 crossref_primary_10_1002_bab_2517 crossref_primary_10_1002_slct_202204050 crossref_primary_10_2174_1570180819666220827162711 crossref_primary_10_2174_1574888X17666220831105257 crossref_primary_10_1002_cbdv_202200656 crossref_primary_10_1002_slct_202302751 crossref_primary_10_1002_jbt_23152 crossref_primary_10_1016_j_pep_2024_106474 crossref_primary_10_1080_1062936X_2023_2240698 crossref_primary_10_1007_s12010_022_04083_4 crossref_primary_10_1016_j_bioorg_2024_107146 crossref_primary_10_1016_j_ijbiomac_2023_128294 crossref_primary_10_1002_ardp_202300497 crossref_primary_10_1016_j_ijbiomac_2023_124232 crossref_primary_10_1007_s11030_023_10774_9 crossref_primary_10_1007_s11030_022_10527_0 crossref_primary_10_1038_s41598_023_50686_0 crossref_primary_10_1016_j_molstruc_2022_134783 crossref_primary_10_1002_cbdv_202301362 crossref_primary_10_1080_07391102_2023_2256876 crossref_primary_10_1002_ardp_202200108 crossref_primary_10_21597_jist_1289203 crossref_primary_10_1002_ddr_22031 crossref_primary_10_1002_ardp_202200554 crossref_primary_10_1002_cbdv_202201190 crossref_primary_10_1016_j_bioorg_2023_106980 crossref_primary_10_1016_j_jddst_2023_104806 crossref_primary_10_1016_j_bmc_2022_117111 crossref_primary_10_1016_j_molstruc_2023_137351 |
| Cites_doi | 10.1016/j.ejmech.2013.11.017 10.36468/pharmaceutical-sciences.629 10.1016/S0021-9258(18)91799-0 10.1002/bab.2107 10.3109/14756366.2012.715287 10.1016/S0021-9258(18)93957-8 10.1002/ddr.21887 10.1080/07391102.2020.1806927 10.1002/jbt.22010 10.1007/s12010-019-03073-3 10.1002/slct.202103100 10.1016/j.ejmech.2018.07.026 10.1111/jphp.13141 10.1002/ardp.202000282 10.3109/14756366.2015.1128426 10.1016/S0968-0896(98)80022-9 10.1016/S0169-409X(96)00423-1 10.1016/j.ejmech.2019.111600 10.1007/s10616-020-00432-5 10.1002/jbt.22385 10.7164/antibiotics.24.443 10.1038/clpt.1983.170 10.1002/slct.201903458 10.1016/j.bioorg.2017.02.007 10.1021/ci700271z 10.1517/13543784.15.12.1507 10.1016/j.bioorg.2019.02.013 10.1002/ardp.202000243 10.1021/ja01318a036 10.1021/ja993663t 10.1002/slct.201902424 10.1002/cphc.201701104 10.1002/ardp.201900383 10.1080/14756366.2020.1746784 10.1080/01480545.2019.1620266 10.1016/j.ejmech.2015.01.008 10.3906/kim-2004-36 10.1007/s11033-019-04706-w 10.1021/ci800324m 10.1016/j.pharep.2013.08.007 10.1016/j.ejmech.2013.03.030 10.1002/ardp.202000230 10.1002/bab.2284 10.1002/slct.202102082 10.1016/j.ijbiomac.2019.09.237 10.1021/jm2013248 10.1080/07391102.2020.1736631 10.2174/1871520620666200218110645 10.1080/07391102.2021.1967195 10.1016/0006-2952(61)90145-9 10.1002/slct.202103197 10.30731/ijcps.7.2.2018.13-26 10.1111/jsr.12956 10.1016/j.arabjc.2010.10.032 10.1007/s11696-019-00988-3 10.1358/dof.2009.34.8.1400202 10.1016/j.envpol.2020.114203 10.1080/07391102.2019.1583606 10.1016/j.bioorg.2020.103897 10.1080/07391102.2020.1790422 10.1016/j.bioorg.2019.103004 10.1111/jphp.13144 10.1080/10942912.2019.1656234 10.1016/j.ejmech.2020.112219 10.1002/ardp.202100294 10.1016/j.ejmech.2011.05.037 10.1007/s42250-019-00084-9 10.1007/s00044-019-02382-w 10.1021/acs.jmedchem.9b02067 10.3760/cma.j.issn.0366-6999.2010.08.021 10.3390/molecules25081789 10.1021/bi201284u 10.1002/ardp.202000102 10.1515/chem-2021-0032 10.1021/jm901137j 10.1021/jm300871x 10.1007/s12010-019-03009-x 10.3390/molecules191117356 10.1021/jm051256o 10.1007/s10822-013-9644-8 10.1016/j.bioorg.2021.105009 10.1002/cbdv.202000958 10.1016/j.ijbiomac.2020.09.043 10.1016/j.ejmech.2011.08.015 10.1016/j.cbi.2016.12.008 10.2174/0929866526666190226162225 10.26452/ijrps.v10i3.1477 10.1002/ardp.202000330 10.1016/S0968-0896(03)00179-2 10.1016/j.jorganchem.2020.121542 10.1016/S0021-9258(18)95800-X 10.1007/s11033-020-05987-2 10.1016/j.etap.2015.11.024 10.2174/1570180817999200520123510 10.1016/j.ejmech.2014.07.052 10.1080/07391102.2021.1916599 10.1002/ddr.21667 10.3109/14756366.2014.959511 |
| ContentType | Journal Article |
| Copyright | The Author(s), under exclusive licence to Springer Nature Switzerland AG 2022 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG. The Author(s), under exclusive licence to Springer Nature Switzerland AG 2022. |
| Copyright_xml | – notice: The Author(s), under exclusive licence to Springer Nature Switzerland AG 2022 – notice: 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG. – notice: The Author(s), under exclusive licence to Springer Nature Switzerland AG 2022. |
| DBID | NPM AAYXX CITATION 3V. 7X7 7XB 88E 88I 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. M0S M1P M2P PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM |
| DOI | 10.1007/s11030-022-10422-8 |
| DatabaseName | PubMed CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Medical Database Science Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | PubMed CrossRef ProQuest Science Journals (Alumni Edition) ProQuest Central Student ProQuest Central Basic ProQuest Central Essentials ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | ProQuest Science Journals (Alumni Edition) PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology Physics |
| EISSN | 1573-501X |
| EndPage | 2845 |
| ExternalDocumentID | 10_1007_s11030_022_10422_8 35397086 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: Research Fund of Erzincan Binali Yıldırım University grantid: TSA-2020-729 – fundername: Research Fund of Anadolu University grantid: 2102S003 – fundername: ; grantid: 2102S003 – fundername: ; grantid: TSA-2020-729 |
| GroupedDBID | --- -4W -58 -5G -BR -EM -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 123 1SB 2.D 203 28- 29M 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 3SX 3V. 4.4 406 408 409 40E 53G 5QI 5VS 67Z 6NX 7X7 88E 88I 8FE 8FH 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AABYN AAFGU AAHNG AAIAL AAJKR AANXM AANZL AAPBV AARHV AARTL AATNV AATVU AAUYE AAWCG AAYFA AAYIU AAYQN AAYTO ABBBX ABBXA ABDZT ABECU ABELW ABFGW ABFTV ABHLI ABHQN ABJNI ABJOX ABKAS ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACBMV ACBRV ACBXY ACBYP ACGFS ACGOD ACHSB ACHXU ACIGE ACIPQ ACKNC ACMDZ ACMLO ACOKC ACOMO ACSNA ACTTH ACVWB ACWMK ADBBV ADHHG ADHIR ADIMF ADINQ ADKNI ADKPE ADMDM ADOAH ADOXG ADRFC ADTPH ADURQ ADYFF ADYPR ADZKW AEBTG AEEQQ AEFIE AEFTE AEGAL AEGNC AEJHL AEJRE AEKMD AENEX AEOHA AEPYU AESKC AESTI AETLH AEVLU AEVTX AEXYK AFEXP AFGCZ AFKRA AFLOW AFNRJ AFQWF AFWTZ AFZKB AGAYW AGDGC AGGBP AGGDS AGJBK AGMZJ AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHMBA AHSBF AHYZX AIAKS AIIXL AILAN AIMYW AITGF AJBLW AJDOV AJRNO AJZVZ AKMHD AKQUC ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG AOSHJ ARMRJ ASPBG AVWKF AXYYD AZFZN AZQEC B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 DWQXO EBD EBLON EBS EIOEI EJD EMOBN EPAXT ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ6 GQ7 GQ8 GXS HCIFZ HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IWAJR IXC IXD IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW LAK LK5 LLZTM M1P M2P M4Y M7R MA- N2Q NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P9N PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RIG RNI RNS ROL RPX RRX RSV RZC RZE RZK S16 S1Z S26 S27 S28 S3B SAP SBY SCLPG SCM SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 T16 TEORI TSG TSK TSV TUC TUS U2A U9L UG4 UKHRP UNUBA UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK6 WK8 YLTOR Z45 Z7U Z7V Z87 Z8O Z8P Z91 ZMTXR ZOVNA ~A9 ~EX ~KM AACDK AAJBT AASML ABAKF ACAOD ACDTI ACZOJ AEFQL AEMSY AFBBN AGQEE AGRTI AIGIU ALIPV NPM AAEOY AAQLM AAYXX CITATION H13 7XB 8FK K9. PQEST PQUKI PRINS Q9U 7X8 5PM |
| ID | FETCH-LOGICAL-c404t-43c3be81d4a3135d7f1ba5419aa617668065e523c0a3bb020af43421948d578c3 |
| IEDL.DBID | BENPR |
| ISSN | 1381-1991 |
| IngestDate | Tue Sep 17 21:14:32 EDT 2024 Fri Aug 16 11:28:14 EDT 2024 Fri Sep 13 05:29:02 EDT 2024 Thu Sep 12 16:58:43 EDT 2024 Sat Sep 28 08:43:52 EDT 2024 Sat Dec 16 12:07:13 EST 2023 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Keywords | 1,3,4-oxadiazol Carbonic anhydrase Acetylcholinesterase substituted sulfonyl amide In silico study N-substituted sulfonyl amide |
| Language | English |
| License | 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c404t-43c3be81d4a3135d7f1ba5419aa617668065e523c0a3bb020af43421948d578c3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-2932-2789 0000-0003-0796-4374 |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC8994094 |
| PMID | 35397086 |
| PQID | 2721075391 |
| PQPubID | 54625 |
| PageCount | 21 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8994094 proquest_miscellaneous_2648899520 proquest_journals_2721075391 crossref_primary_10_1007_s11030_022_10422_8 pubmed_primary_35397086 springer_journals_10_1007_s11030_022_10422_8 |
| PublicationCentury | 2000 |
| PublicationDate | 2022-10-01 |
| PublicationDateYYYYMMDD | 2022-10-01 |
| PublicationDate_xml | – month: 10 year: 2022 text: 2022-10-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Cham |
| PublicationPlace_xml | – name: Cham – name: Netherlands – name: Dordrecht |
| PublicationTitle | Molecular diversity |
| PublicationTitleAbbrev | Mol Divers |
| PublicationTitleAlternate | Mol Divers |
| PublicationYear | 2022 |
| Publisher | Springer International Publishing Springer Nature B.V |
| Publisher_xml | – name: Springer International Publishing – name: Springer Nature B.V |
| References | KilicABeyazsakalLIşıkMTürkeşCNecipATakımKMannich reaction derived novel boron complexes with amine-bis(phenolate) ligands: synthesis, spectroscopy and in vitro/in silico biological studiesJ Organomet Chem202010.1016/j.jorganchem.2020.121542 BarreiroGGuimarãesCRTubert-BrohmanILyonsTMTirado-RivesJJorgensenWLSearch for non-nucleoside inhibitors of HIV-1 reverse transcriptase using chemical similarity, molecular docking, and MM-GB/SA scoringJ Chem Inf Model2007476241624281:CAS:528:DC%2BD2sXhtF2gsrjP10.1021/ci700271z179490712564819 DemirYThe behaviour of some antihypertension drugs on human serum paraoxonase-1: an important protector enzyme against atherosclerosisJ Pharm Pharmacol20197110157615831:CAS:528:DC%2BC1MXhsVequr%2FI10.1111/jphp.1314431347707 BozdagMFerraroniMWardCCartaFBuaSAngeliACarbonic anhydrase inhibitors based on sorafenib scaffold: design, synthesis, crystallographic investigation and effects on primary breast cancer cellsEur J Med Chem201910.1016/j.ejmech.2019.11160031419777 CaglayanCGulcinİThe toxicological effects of some avermectins on goat liver carbonic anhydrase enzymeJ Biochem Mol Toxicol20183211:CAS:528:DC%2BC2sXhsl2nt7bN10.1002/jbt.22010 BeydemirŞTürkeşCYalçınAGadolinium-based contrast agents: in vitro paraoxonase 1 inhibition, in silico studiesDrug Chem Toxicol20214455085171:CAS:528:DC%2BC1MXhtFeqtrrN10.1080/01480545.2019.162026631179770 LineweaverHBurkDThe determination of enzyme dissociation constantsJ Am Chem Soc19345636586661:CAS:528:DyaA2cXisF2ltg%3D%3D10.1021/ja01318a036 DemirYTürkeşCBeydemirŞMolecular docking studies and inhibition properties of some antineoplastic agents against paraoxonase-IAnti-Cancer Agents Med Chem20202078878961:CAS:528:DC%2BB3cXhslSksL3O10.2174/1871520620666200218110645 GalalAMFayadWMettwallyWSGomaaSKAhmedEREl-RefaiHACytotoxicity of multicellular cancer spheroids, antibacterial, and antifungal of selected sulfonamide derivatives coupled with a salicylamide and/or anisamide scaffoldMed Chem Res2019289142514401:CAS:528:DC%2BC1MXhtFOrsbvK10.1007/s00044-019-02382-w DemirYNaphthoquinones, benzoquinones, and anthraquinones: Molecular docking, ADME and inhibition studies on human serum paraoxonase-1 associated with cardiovascular diseasesDrug Dev Res20208156286361:CAS:528:DC%2BB3cXlvFSjur0%3D10.1002/ddr.2166732232985 SzychowskiKALejaMLKaminskyyDVBindugaUEPinyazhkoRLesykRBStudy of novel anticancer 4-thiazolidinone derivativesChem-Biol Interact201710.1016/j.cbi.2016.12.00827965178 AkocakSTaslimiPLolakNIşıkMDurgunMBudakYSynthesis, characterization, and inhibition study of novel substituted phenylureido sulfaguanidine derivatives as α-glycosidase and cholinesterase inhibitorsChem Biodivers20211841:CAS:528:DC%2BB3MXlvValtbg%3D10.1002/cbdv.20200095833620128 DeraweySHMosaMNJasimEQHraishawiRMSynthesis, characterization and antibacterial evaluation of 1,3,4-oxadiazole derivativesInt J Res Pharm Sci2019103234223501:CAS:528:DC%2BB3cXmtFWrt78%3D10.26452/ijrps.v10i3.1477 YamaliCGülHİDemirYKazazCGülçinİSynthesis and bioactivities of 1-(4-hydroxyphenyl)-2-((heteroaryl) thio) ethanones as carbonic anhydrase I, II and acetylcholinesterase inhibitorsTurk J Chem2020444105810671:CAS:528:DC%2BB3cXhslKmu73N10.3906/kim-2004-36334882127751916 GündoğduSTürkeşCArslanMDemirYBeydemirŞNew Isoindole-1, 3-dione substituted sulfonamides as potent inhibitors of carbonic anhydrase and acetylcholinesterase: design, synthesis, and biological evaluationChemistrySelect201944513347133551:CAS:528:DC%2BC1MXitleqt7zO10.1002/slct.201903458 ÇalışkanBDemirYTürkeşCOphthalmic drugs: in vitro paraoxonase 1 inhibition and molecular docking studiesBiotechnol Appl Biochem202110.1002/bab.228434786760 HalgrenTAIdentifying and characterizing binding sites and assessing druggabilityJ Chem Inf Model20094923773891:CAS:528:DC%2BD1MXns1OhsA%3D%3D10.1021/ci800324m19434839 AydinBOAnilDDemirYSynthesis of N-alkylated pyrazolo[3,4‐d] pyrimidine analogs and evaluation of acetylcholinesterase and carbonic anhydrase inhibition propertiesArch Pharm2021354520003301:CAS:528:DC%2BB3MXitFahs7o%3D10.1002/ardp.202000330 BanoSJavedKAhmadSRathishISinghSAlamMSynthesis and biological evaluation of some new 2-pyrazolines bearing benzene sulfonamide moiety as potential anti-inflammatory and anti-cancer agentsEur J Med Chem20114612576357681:CAS:528:DC%2BC3MXhsVKqtLzJ10.1016/j.ejmech.2011.08.01522019186 TurkanFÇetinATaslimiPKaramanMGulçinİSynthesis, biological evaluation and molecular docking of novel pyrazole derivatives as potent carbonic anhydrase and acetylcholinesterase inhibitorsBioorg Chem201910.1016/j.bioorg.2019.02.01331677859 TürkeşCKesebir ÖztürkADemirYKüfrevioğluÖİBeydemirŞCalcium channel blockers: the effect of glutathione S-transferase enzyme activity and molecular docking studiesChemistrySelect202164011137111431:CAS:528:DC%2BB3MXitlOmtbrF10.1002/slct.202103100 BilginerSGulHIAnilBDemirYGulcinISynthesis and in silico studies of triazene-substituted sulfamerazine derivatives as acetylcholinesterase and carbonic anhydrases inhibitorsArch Pharm2021354120002431:CAS:528:DC%2BB3cXhvFWmtb%2FO10.1002/ardp.202000243 SeverBAltıntopMDDemirYTürkeşCÖzbaşKÇiftçiGAA new series of 2,4-thiazolidinediones endowed with potent aldose reductase inhibitory activityOpen Chem202110.1515/chem-2021-0032 YamaliCGulHICakirTDemirYGulcinIAminoalkylated phenolic chalcones: investigation of biological effects on acetylcholinesterase and carbonic anhydrase I and II as potential lead enzyme inhibitorsLett Drug Des Discov20201710128312921:CAS:528:DC%2BB3cXit1Gksb7J10.2174/1570180817999200520123510 NalciOBNadarogluHGencSHacimuftuogluAAlayliAThe effects of MgS nanoparticles-Cisplatin-bio-conjugate on SH-SY5Y neuroblastoma cell lineMol Biol Rep20204712971597231:CAS:528:DC%2BB3cXitlCis73M10.1007/s11033-020-05987-233191478 KrzywikJMozgaWAminpourMJanczakJMajEWietrzykJSynthesis, antiproliferative activity and molecular docking studies of novel doubly modified colchicine amides and sulfonamides as anticancer agentsMolecules202025817891:CAS:528:DC%2BB3cXpvFKnsro%3D10.3390/molecules250817897221574 IşıkMDemirYDurgunMTürkeşCNecipABeydemirŞMolecular docking and investigation of 4-(benzylideneamino)-and 4-(benzylamino)-benzenesulfonamide derivatives as potent AChE inhibitorsChem Pap202010.1007/s11696-019-00988-3 CheungJRudolphMJBurshteynFCassidyMSGaryENLoveJStructures of human acetylcholinesterase in complex with pharmacologically important ligandsJ Med Chem2012552210282102861:CAS:528:DC%2BC38XhsVGqtLnN10.1021/jm300871x23035744 TürkeşCDemirYBeydemirŞAnti-diabetic properties of calcium channel blockers: inhibition effects on aldose reductase enzyme activityAppl Biochem Biotechnol201918913183291:CAS:528:DC%2BC1MXosF2rt7g%3D10.1007/s12010-019-03009-x30980289 JohnsonKAGoodyRSThe original Michaelis constant: translation of the 1913 Michaelis–Menten paperBiochemistry20115039826482691:CAS:528:DC%2BC3MXhtFCjtbbE10.1021/bi201284u21888353 TürkeşCSöyütHBeydemirŞHuman serum paraoxonase-1 (hPON1): in vitro inhibition effects of moxifloxacin hydrochloride, levofloxacin hemihidrate, cefepime hydrochloride, cefotaxime sodium and ceftizoxime sodiumJ Enzyme Inhib Med Chem20153046226281:CAS:528:DC%2BC2MXhtFyjtrzJ10.3109/14756366.2014.95951125519764 El-SayedNSEl-BendaryEREl-AshrySMEl-KerdawyMMSynthesis and antitumor activity of new sulfonamide derivatives of thiadiazolo [3, 2-a] pyrimidinesEur J Med Chem2011469371437201:CAS:528:DC%2BC3MXhtV2rt7rF10.1016/j.ejmech.2011.05.03721705114 TürkeşCSöyütHBeydemirŞIn vitro inhibitory effects of palonosetron hydrochloride, bevacizumab and cyclophosphamide on purified paraoxonase-I (hPON1) from human serumEnviron Toxicol Pharmacol201610.1016/j.etap.2015.11.02426915059 TürkeşCInvestigation of potential paraoxonase-I inhibitors by kinetic and molecular docking studies: chemotherapeutic drugsProtein Pept Lett20192663924021:CAS:528:DC%2BC1MXhtl2qsrbP10.2174/092986652666619022616222530819074 TripathiACGuptaSJFatimaGNSonarPKVermaASarafSK4-Thiazolidinones: the advances continue…Eur J Med Chem201410.1016/j.ejmech.2013.11.01724929294 VerpoorteJAMehtaSEdsallJTEsterase activities of human carbonic anhydrases B and CJ Biol Chem196724218422142291:CAS:528:DyaF2sXkvFOhsbw%3D10.1016/S0021-9258(18)95800-X4964830 FriesnerRAMurphyRBRepaskyMPFryeLLGreenwoodJRHalgrenTAExtra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein−ligand complexesJ Med Chem20064921617761961:CAS:528:DC%2BD28XpvVGmurg%3D10.1021/jm051256o17034125 AkbabaYTürkeşCPolatLSöyütHŞahinEMenzekASynthesis and paroxonase activities of novel bromophenolsJ Enzyme Inhib Med Chem2013285107310791:CAS:528:DC%2BC3sXhsVSlsb%2FF10.3109/14756366.2012.71528722994801 JamesNDGrowcottJWZibotentan endothelin ETA receptor antagonist oncolyticDrugs Future20093486246331:CAS:528:DC%2BC3cXhs1alsw%3D%3D10.1358/dof.2009.34.8.1400202 TürkeşCSöyütHBeydemirŞEffect of calcium channel blockers on paraoxonase-1 (PON1) activity and oxidative stressPharmacol Rep201466174801:CAS:528:DC%2BC2MXmt1Sis7g%3D10.1016/j.pharep.2013.08.00724905310 VardanSSmulyanHMookherjeeSEichREffects of tiodazosin, a new antihypertensive, hemodynamics and clinical variablesClin Pharmacol Ther19833432902961:STN:280:DyaL3s3os1ahuw%3D%3D10.1038/clpt.1983.1706883905 JohanssonAPoliakovAÅkerblomEWiklundKLindebergGWiniwarterSAcyl sulfonamides as potent protease inhibitors of the hepatitis C virus full-length NS3 (protease-helicase/NTPase): a comparative study of different C-terminalsBioorg Med Chem20031112255125681:CAS:528:DC%2BD3sXjvFeksr8%3D10.1016/S0968-0896(03)00179-212757723 SuryawanshiRJadhavSMakwanaNDesaiDChaturbhujDSonawaniAEvaluation of 4-thiazolidinone derivatives as potential reverse transcriptase inhibitors against HIV-1 drug resistant strainsBioorg Chem201710.1016/j.bioorg.2017.02.00728236450 TugrakMGulHIDemirYGulcinISynthesis of benzamide derivatives with thiourea-substituted benzenesulfonamides as carbonic anhydrase inhibitorsArch Pharm202035421:CAS:528:DC%2BB3cXitVagurjE10.1002/ardp.202000230 SastryGMAdzhigireyMDayTAnnabhimojuRShermanWProtein and ligand preparation: F Turkan (10422_CR34) 2019 M Işık (10422_CR76) 2020 ND James (10422_CR13) 2009; 34 C Türkeş (10422_CR55) 2014; 66 BO Aydin (10422_CR33) 2021; 354 CA Lipinski (10422_CR71) 1997; 23 C Caglayan (10422_CR48) 2018; 32 C Türkeş (10422_CR95) 2021 C Yamali (10422_CR30) 2020; 44 T Nasr (10422_CR25) 2014 J Boström (10422_CR11) 2012; 55 Y Demir (10422_CR53) 2020; 81 G Barreiro (10422_CR93) 2007; 47 S Akocak (10422_CR31) 2021; 18 C Türkeş (10422_CR50) 2021; 6 S Vardan (10422_CR15) 1983; 34 A Ece (10422_CR92) 2020; 38 S Kılıcaslan (10422_CR98) 2016; 31 C Türkeş (10422_CR40) 2019 S Bano (10422_CR20) 2011; 46 M Durgun (10422_CR27) 2020; 35 A Taghizadehghalehjoughi (10422_CR63) 2019; 46 OB Nalci (10422_CR65) 2020; 47 Q Istrefi (10422_CR38) 2020; 353 N Hasbullah (10422_CR61) 2013 S Askin (10422_CR45) 2021 K Rutkauskas (10422_CR100) 2014; 19 Ü Yaşar (10422_CR94) 2021; 29 GM Sastry (10422_CR84) 2013; 27 H Lineweaver (10422_CR52) 1934; 56 P Dholaria (10422_CR10) 2018; 7 MA Bhat (10422_CR3) 2014; 71 KA Scheidt (10422_CR29) 1998; 6 H-r Xie (10422_CR101) 2010; 123 DP Richey (10422_CR22) 1969; 244 A Pecina (10422_CR82) 2018; 19 GM Brown (10422_CR23) 1962; 237 M Bozdag (10422_CR81) 2019 N Lolak (10422_CR88) 2020 M Işık (10422_CR69) 2020; 353 Y Demir (10422_CR91) 2020; 20 A Savarino (10422_CR12) 2006; 15 V Sharma (10422_CR99) 2020 E Hoff (10422_CR39) 2020; 29 C Türkeş (10422_CR74) 2019; 71 M Işık (10422_CR68) 2020 C Türkeş (10422_CR86) 2020; 190 B Sever (10422_CR35) 2020 J Cheung (10422_CR80) 2012; 55 A Kunzler (10422_CR7) 2013 M Ogata (10422_CR14) 1971; 24 A Deep (10422_CR6) 2014; 7 SH Derawey (10422_CR8) 2019; 10 J Sahoo (10422_CR24) 2020; 82 KA Szychowski (10422_CR4) 2017 J Li (10422_CR21) 2015; 92 SG Nayak (10422_CR9) 2019 EM Duffy (10422_CR72) 2000; 122 B Sever (10422_CR79) 2021 C Türkeş (10422_CR57) 2016 C Türkeş (10422_CR59) 2019; 189 TA Halgren (10422_CR87) 2009; 49 ME Valencia (10422_CR62) 2018 AM Galal (10422_CR19) 2019; 28 FS Tokalı (10422_CR51) 2021 A Kilic (10422_CR77) 2020 P Taslimi (10422_CR28) 2020 JB Baell (10422_CR73) 2010; 53 J Krzywik (10422_CR16) 2020; 25 F Topal (10422_CR47) 2019; 33 RA Friesner (10422_CR90) 2006; 49 AC Tripathi (10422_CR2) 2014 JJ Li (10422_CR1) 2013 M Topal (10422_CR43) 2019; 22 C Türkeş (10422_CR83) 2019; 4 R Suryawanshi (10422_CR5) 2017 NS El-Sayed (10422_CR17) 2011; 46 GL Ellman (10422_CR42) 1961; 7 C Türkeş (10422_CR96) 2021; 6 S Gündoğdu (10422_CR78) 2019; 4 Ş Beydemir (10422_CR75) 2021; 44 B Çalışkan (10422_CR54) 2021; 69 B Çalışkan (10422_CR97) 2021 A Johansson (10422_CR18) 2003; 11 Y Demir (10422_CR60) 2019; 71 C Yamali (10422_CR44) 2020; 17 M Tugrak (10422_CR37) 2020; 354 JA Verpoorte (10422_CR46) 1967; 242 Y Lv (10422_CR26) 2020 Y Demir (10422_CR85) 2021 C Türkeş (10422_CR67) 2019; 26 B Sever (10422_CR89) 2021; 354 S Bilginer (10422_CR41) 2021; 354 M Kalaycı (10422_CR32) 2020; 354 MS Ertugrul (10422_CR64) 2020; 72 KA Johnson (10422_CR49) 2011; 50 WC Wright (10422_CR66) 2020; 63 C Türkeş (10422_CR70) 2022; 40 C Türkeş (10422_CR56) 2015; 30 Y Akbaba (10422_CR58) 2013; 28 C Türkeş (10422_CR36) 2021; 39 |
| References_xml | – year: 2014 ident: 10422_CR2 publication-title: Eur J Med Chem doi: 10.1016/j.ejmech.2013.11.017 contributor: fullname: AC Tripathi – volume: 82 start-page: 123 issue: 1 year: 2020 ident: 10422_CR24 publication-title: Indian J Pharm Sci doi: 10.36468/pharmaceutical-sciences.629 contributor: fullname: J Sahoo – volume: 244 start-page: 1582 issue: 6 year: 1969 ident: 10422_CR22 publication-title: J Biol Chem doi: 10.1016/S0021-9258(18)91799-0 contributor: fullname: DP Richey – start-page: 160 volume-title: Advanced Materials Research year: 2013 ident: 10422_CR61 contributor: fullname: N Hasbullah – volume: 69 start-page: 281 issue: 1 year: 2021 ident: 10422_CR54 publication-title: Biotechnol Appl Biochem doi: 10.1002/bab.2107 contributor: fullname: B Çalışkan – volume: 28 start-page: 1073 issue: 5 year: 2013 ident: 10422_CR58 publication-title: J Enzyme Inhib Med Chem doi: 10.3109/14756366.2012.715287 contributor: fullname: Y Akbaba – volume: 237 start-page: 536 issue: 2 year: 1962 ident: 10422_CR23 publication-title: J Biol Chem doi: 10.1016/S0021-9258(18)93957-8 contributor: fullname: GM Brown – year: 2021 ident: 10422_CR51 publication-title: Drug Dev Res doi: 10.1002/ddr.21887 contributor: fullname: FS Tokalı – volume: 40 start-page: 77 issue: 1 year: 2022 ident: 10422_CR70 publication-title: J Biomol Struct Dyn doi: 10.1080/07391102.2020.1806927 contributor: fullname: C Türkeş – volume: 32 issue: 1 year: 2018 ident: 10422_CR48 publication-title: J Biochem Mol Toxicol doi: 10.1002/jbt.22010 contributor: fullname: C Caglayan – volume: 190 start-page: 252 issue: 1 year: 2020 ident: 10422_CR86 publication-title: Appl Biochem Biotechnol doi: 10.1007/s12010-019-03073-3 contributor: fullname: C Türkeş – volume: 6 start-page: 11137 issue: 40 year: 2021 ident: 10422_CR50 publication-title: ChemistrySelect doi: 10.1002/slct.202103100 contributor: fullname: C Türkeş – year: 2018 ident: 10422_CR62 publication-title: Eur J Med Chem doi: 10.1016/j.ejmech.2018.07.026 contributor: fullname: ME Valencia – volume: 71 start-page: 1553 issue: 10 year: 2019 ident: 10422_CR74 publication-title: J Pharm Pharmacol doi: 10.1111/jphp.13141 contributor: fullname: C Türkeş – volume: 354 issue: 3 year: 2020 ident: 10422_CR32 publication-title: Arch Pharm doi: 10.1002/ardp.202000282 contributor: fullname: M Kalaycı – volume: 31 start-page: 1300 issue: 6 year: 2016 ident: 10422_CR98 publication-title: J Enzyme Inhib Med Chem doi: 10.3109/14756366.2015.1128426 contributor: fullname: S Kılıcaslan – volume: 6 start-page: 2477 issue: 12 year: 1998 ident: 10422_CR29 publication-title: Bioorg Med Chem doi: 10.1016/S0968-0896(98)80022-9 contributor: fullname: KA Scheidt – volume: 23 start-page: 3 issue: 1–3 year: 1997 ident: 10422_CR71 publication-title: Adv Drug Deliv Rev doi: 10.1016/S0169-409X(96)00423-1 contributor: fullname: CA Lipinski – year: 2019 ident: 10422_CR81 publication-title: Eur J Med Chem doi: 10.1016/j.ejmech.2019.111600 contributor: fullname: M Bozdag – volume: 72 start-page: 885 issue: 6 year: 2020 ident: 10422_CR64 publication-title: Cytotechnology doi: 10.1007/s10616-020-00432-5 contributor: fullname: MS Ertugrul – volume: 33 issue: 10 year: 2019 ident: 10422_CR47 publication-title: J Biochem Mol Toxicol doi: 10.1002/jbt.22385 contributor: fullname: F Topal – volume: 24 start-page: 443 issue: 7 year: 1971 ident: 10422_CR14 publication-title: J Antibiotics doi: 10.7164/antibiotics.24.443 contributor: fullname: M Ogata – volume: 34 start-page: 290 issue: 3 year: 1983 ident: 10422_CR15 publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.1983.170 contributor: fullname: S Vardan – volume: 4 start-page: 13347 issue: 45 year: 2019 ident: 10422_CR78 publication-title: ChemistrySelect doi: 10.1002/slct.201903458 contributor: fullname: S Gündoğdu – year: 2017 ident: 10422_CR5 publication-title: Bioorg Chem doi: 10.1016/j.bioorg.2017.02.007 contributor: fullname: R Suryawanshi – volume: 47 start-page: 2416 issue: 6 year: 2007 ident: 10422_CR93 publication-title: J Chem Inf Model doi: 10.1021/ci700271z contributor: fullname: G Barreiro – volume: 15 start-page: 1507 issue: 12 year: 2006 ident: 10422_CR12 publication-title: Expert Opin Invest Drugs doi: 10.1517/13543784.15.12.1507 contributor: fullname: A Savarino – year: 2019 ident: 10422_CR34 publication-title: Bioorg Chem doi: 10.1016/j.bioorg.2019.02.013 contributor: fullname: F Turkan – volume: 354 start-page: 2000243 issue: 1 year: 2021 ident: 10422_CR41 publication-title: Arch Pharm doi: 10.1002/ardp.202000243 contributor: fullname: S Bilginer – volume: 56 start-page: 658 issue: 3 year: 1934 ident: 10422_CR52 publication-title: J Am Chem Soc doi: 10.1021/ja01318a036 contributor: fullname: H Lineweaver – volume: 122 start-page: 2878 issue: 12 year: 2000 ident: 10422_CR72 publication-title: J Am Chem Soc doi: 10.1021/ja993663t contributor: fullname: EM Duffy – volume: 4 start-page: 9731 issue: 33 year: 2019 ident: 10422_CR83 publication-title: ChemistrySelect doi: 10.1002/slct.201902424 contributor: fullname: C Türkeş – volume: 19 start-page: 873 issue: 7 year: 2018 ident: 10422_CR82 publication-title: ChemPhysChem doi: 10.1002/cphc.201701104 contributor: fullname: A Pecina – volume: 353 issue: 6 year: 2020 ident: 10422_CR38 publication-title: Arch Pharm doi: 10.1002/ardp.201900383 contributor: fullname: Q Istrefi – volume: 35 start-page: 950 issue: 1 year: 2020 ident: 10422_CR27 publication-title: J Enzyme Inhib Med Chem doi: 10.1080/14756366.2020.1746784 contributor: fullname: M Durgun – volume: 44 start-page: 508 issue: 5 year: 2021 ident: 10422_CR75 publication-title: Drug Chem Toxicol doi: 10.1080/01480545.2019.1620266 contributor: fullname: Ş Beydemir – volume: 92 start-page: 370 year: 2015 ident: 10422_CR21 publication-title: Eur J Med Chem doi: 10.1016/j.ejmech.2015.01.008 contributor: fullname: J Li – volume: 44 start-page: 1058 issue: 4 year: 2020 ident: 10422_CR30 publication-title: Turk J Chem doi: 10.3906/kim-2004-36 contributor: fullname: C Yamali – volume: 46 start-page: 2523 issue: 2 year: 2019 ident: 10422_CR63 publication-title: Mol Biol Rep doi: 10.1007/s11033-019-04706-w contributor: fullname: A Taghizadehghalehjoughi – volume: 49 start-page: 377 issue: 2 year: 2009 ident: 10422_CR87 publication-title: J Chem Inf Model doi: 10.1021/ci800324m contributor: fullname: TA Halgren – volume: 66 start-page: 74 issue: 1 year: 2014 ident: 10422_CR55 publication-title: Pharmacol Rep doi: 10.1016/j.pharep.2013.08.007 contributor: fullname: C Türkeş – year: 2013 ident: 10422_CR7 publication-title: Eur J Med Chem doi: 10.1016/j.ejmech.2013.03.030 contributor: fullname: A Kunzler – volume: 354 issue: 2 year: 2020 ident: 10422_CR37 publication-title: Arch Pharm doi: 10.1002/ardp.202000230 contributor: fullname: M Tugrak – year: 2021 ident: 10422_CR97 publication-title: Biotechnol Appl Biochem doi: 10.1002/bab.2284 contributor: fullname: B Çalışkan – volume: 29 start-page: 7278 issue: 6 year: 2021 ident: 10422_CR94 publication-title: ChemistrySelect doi: 10.1002/slct.202102082 contributor: fullname: Ü Yaşar – year: 2020 ident: 10422_CR68 publication-title: Int J Biol Macromol doi: 10.1016/j.ijbiomac.2019.09.237 contributor: fullname: M Işık – volume: 55 start-page: 1817 issue: 5 year: 2012 ident: 10422_CR11 publication-title: J Med Chem doi: 10.1021/jm2013248 contributor: fullname: J Boström – volume: 39 start-page: 1672 issue: 5 year: 2021 ident: 10422_CR36 publication-title: J Biomol Struct Dyn doi: 10.1080/07391102.2020.1736631 contributor: fullname: C Türkeş – volume: 20 start-page: 887 issue: 7 year: 2020 ident: 10422_CR91 publication-title: Anti-Cancer Agents Med Chem doi: 10.2174/1871520620666200218110645 contributor: fullname: Y Demir – year: 2021 ident: 10422_CR85 publication-title: J Biomol Struct Dyn doi: 10.1080/07391102.2021.1967195 contributor: fullname: Y Demir – volume: 7 start-page: 88 issue: 2 year: 1961 ident: 10422_CR42 publication-title: Biochem Pharmacol doi: 10.1016/0006-2952(61)90145-9 contributor: fullname: GL Ellman – volume: 6 start-page: 11915 issue: 43 year: 2021 ident: 10422_CR96 publication-title: ChemistrySelect doi: 10.1002/slct.202103197 contributor: fullname: C Türkeş – volume: 7 start-page: 13 issue: 2 year: 2018 ident: 10422_CR10 publication-title: Int J Chem Phys Sci doi: 10.30731/ijcps.7.2.2018.13-26 contributor: fullname: P Dholaria – volume: 29 issue: 2 year: 2020 ident: 10422_CR39 publication-title: J Sleep Res doi: 10.1111/jsr.12956 contributor: fullname: E Hoff – volume: 7 start-page: 287 issue: 3 year: 2014 ident: 10422_CR6 publication-title: Arabian J Chem doi: 10.1016/j.arabjc.2010.10.032 contributor: fullname: A Deep – year: 2020 ident: 10422_CR76 publication-title: Chem Pap doi: 10.1007/s11696-019-00988-3 contributor: fullname: M Işık – volume: 34 start-page: 624 issue: 8 year: 2009 ident: 10422_CR13 publication-title: Drugs Future doi: 10.1358/dof.2009.34.8.1400202 contributor: fullname: ND James – year: 2020 ident: 10422_CR26 publication-title: Environ Pollut doi: 10.1016/j.envpol.2020.114203 contributor: fullname: Y Lv – volume: 38 start-page: 565 issue: 2 year: 2020 ident: 10422_CR92 publication-title: J Biomol Struct Dyn doi: 10.1080/07391102.2019.1583606 contributor: fullname: A Ece – year: 2020 ident: 10422_CR88 publication-title: Bioorg Chem doi: 10.1016/j.bioorg.2020.103897 contributor: fullname: N Lolak – year: 2020 ident: 10422_CR28 publication-title: J Biomol Struct Dyn doi: 10.1080/07391102.2020.1790422 contributor: fullname: P Taslimi – year: 2019 ident: 10422_CR40 publication-title: Bioorg Chem doi: 10.1016/j.bioorg.2019.103004 contributor: fullname: C Türkeş – volume: 71 start-page: 1576 issue: 10 year: 2019 ident: 10422_CR60 publication-title: J Pharm Pharmacol doi: 10.1111/jphp.13144 contributor: fullname: Y Demir – volume: 22 start-page: 1527 issue: 1 year: 2019 ident: 10422_CR43 publication-title: Int J Food Prop doi: 10.1080/10942912.2019.1656234 contributor: fullname: M Topal – year: 2020 ident: 10422_CR99 publication-title: Eur J Med Chem doi: 10.1016/j.ejmech.2020.112219 contributor: fullname: V Sharma – volume: 354 issue: 12 year: 2021 ident: 10422_CR89 publication-title: Arch Pharm doi: 10.1002/ardp.202100294 contributor: fullname: B Sever – volume: 46 start-page: 3714 issue: 9 year: 2011 ident: 10422_CR17 publication-title: Eur J Med Chem doi: 10.1016/j.ejmech.2011.05.037 contributor: fullname: NS El-Sayed – year: 2019 ident: 10422_CR9 publication-title: Chem Afr doi: 10.1007/s42250-019-00084-9 contributor: fullname: SG Nayak – volume: 28 start-page: 1425 issue: 9 year: 2019 ident: 10422_CR19 publication-title: Med Chem Res doi: 10.1007/s00044-019-02382-w contributor: fullname: AM Galal – volume: 63 start-page: 1415 issue: 3 year: 2020 ident: 10422_CR66 publication-title: J Med Chem doi: 10.1021/acs.jmedchem.9b02067 contributor: fullname: WC Wright – volume: 123 start-page: 1086 issue: 8 year: 2010 ident: 10422_CR101 publication-title: Chinese Med J doi: 10.3760/cma.j.issn.0366-6999.2010.08.021 contributor: fullname: H-r Xie – volume: 25 start-page: 1789 issue: 8 year: 2020 ident: 10422_CR16 publication-title: Molecules doi: 10.3390/molecules25081789 contributor: fullname: J Krzywik – volume: 50 start-page: 8264 issue: 39 year: 2011 ident: 10422_CR49 publication-title: Biochemistry doi: 10.1021/bi201284u contributor: fullname: KA Johnson – volume: 353 issue: 9 year: 2020 ident: 10422_CR69 publication-title: Arch Pharm doi: 10.1002/ardp.202000102 contributor: fullname: M Işık – year: 2021 ident: 10422_CR79 publication-title: Open Chem doi: 10.1515/chem-2021-0032 contributor: fullname: B Sever – volume: 53 start-page: 2719 issue: 7 year: 2010 ident: 10422_CR73 publication-title: J Med Chem doi: 10.1021/jm901137j contributor: fullname: JB Baell – volume: 55 start-page: 10282 issue: 22 year: 2012 ident: 10422_CR80 publication-title: J Med Chem doi: 10.1021/jm300871x contributor: fullname: J Cheung – volume: 189 start-page: 318 issue: 1 year: 2019 ident: 10422_CR59 publication-title: Appl Biochem Biotechnol doi: 10.1007/s12010-019-03009-x contributor: fullname: C Türkeş – volume: 19 start-page: 17356 issue: 11 year: 2014 ident: 10422_CR100 publication-title: Molecules doi: 10.3390/molecules191117356 contributor: fullname: K Rutkauskas – volume: 71 start-page: 763 issue: 5 year: 2014 ident: 10422_CR3 publication-title: Acta Pol Pharm contributor: fullname: MA Bhat – volume: 49 start-page: 6177 issue: 21 year: 2006 ident: 10422_CR90 publication-title: J Med Chem doi: 10.1021/jm051256o contributor: fullname: RA Friesner – volume: 27 start-page: 221 issue: 3 year: 2013 ident: 10422_CR84 publication-title: J Comput-Aided Mol Des doi: 10.1007/s10822-013-9644-8 contributor: fullname: GM Sastry – year: 2021 ident: 10422_CR45 publication-title: Bioorg Chem doi: 10.1016/j.bioorg.2021.105009 contributor: fullname: S Askin – volume: 18 issue: 4 year: 2021 ident: 10422_CR31 publication-title: Chem Biodivers doi: 10.1002/cbdv.202000958 contributor: fullname: S Akocak – year: 2020 ident: 10422_CR35 publication-title: Int J Biol Macromol doi: 10.1016/j.ijbiomac.2020.09.043 contributor: fullname: B Sever – volume: 46 start-page: 5763 issue: 12 year: 2011 ident: 10422_CR20 publication-title: Eur J Med Chem doi: 10.1016/j.ejmech.2011.08.015 contributor: fullname: S Bano – year: 2017 ident: 10422_CR4 publication-title: Chem-Biol Interact doi: 10.1016/j.cbi.2016.12.008 contributor: fullname: KA Szychowski – volume: 26 start-page: 392 issue: 6 year: 2019 ident: 10422_CR67 publication-title: Protein Pept Lett doi: 10.2174/0929866526666190226162225 contributor: fullname: C Türkeş – volume: 10 start-page: 2342 issue: 3 year: 2019 ident: 10422_CR8 publication-title: Int J Res Pharm Sci doi: 10.26452/ijrps.v10i3.1477 contributor: fullname: SH Derawey – volume: 354 start-page: 2000330 issue: 5 year: 2021 ident: 10422_CR33 publication-title: Arch Pharm doi: 10.1002/ardp.202000330 contributor: fullname: BO Aydin – volume: 11 start-page: 2551 issue: 12 year: 2003 ident: 10422_CR18 publication-title: Bioorg Med Chem doi: 10.1016/S0968-0896(03)00179-2 contributor: fullname: A Johansson – year: 2020 ident: 10422_CR77 publication-title: J Organomet Chem doi: 10.1016/j.jorganchem.2020.121542 contributor: fullname: A Kilic – volume: 242 start-page: 4221 issue: 18 year: 1967 ident: 10422_CR46 publication-title: J Biol Chem doi: 10.1016/S0021-9258(18)95800-X contributor: fullname: JA Verpoorte – volume: 47 start-page: 9715 issue: 12 year: 2020 ident: 10422_CR65 publication-title: Mol Biol Rep doi: 10.1007/s11033-020-05987-2 contributor: fullname: OB Nalci – year: 2016 ident: 10422_CR57 publication-title: Environ Toxicol Pharmacol doi: 10.1016/j.etap.2015.11.024 contributor: fullname: C Türkeş – volume: 17 start-page: 1283 issue: 10 year: 2020 ident: 10422_CR44 publication-title: Lett Drug Des Discov doi: 10.2174/1570180817999200520123510 contributor: fullname: C Yamali – year: 2014 ident: 10422_CR25 publication-title: Eur J Med Chem doi: 10.1016/j.ejmech.2014.07.052 contributor: fullname: T Nasr – year: 2021 ident: 10422_CR95 publication-title: J Biomol Struct Dyn doi: 10.1080/07391102.2021.1916599 contributor: fullname: C Türkeş – volume: 81 start-page: 628 issue: 5 year: 2020 ident: 10422_CR53 publication-title: Drug Dev Res doi: 10.1002/ddr.21667 contributor: fullname: Y Demir – volume-title: Heterocyclic chemistry in drug discovery year: 2013 ident: 10422_CR1 contributor: fullname: JJ Li – volume: 30 start-page: 622 issue: 4 year: 2015 ident: 10422_CR56 publication-title: J Enzyme Inhib Med Chem doi: 10.3109/14756366.2014.959511 contributor: fullname: C Türkeş |
| SSID | ssj0010013 |
| Score | 2.5694737 |
| Snippet | The acetylcholinesterase and carbonic anhydrase inhibitors (AChEIs and
h
CAIs) remain key therapeutic agents for many bioactivities such as anti-Alzheimer and... The acetylcholinesterase and carbonic anhydrase inhibitors (AChEIs and hCAIs) remain key therapeutic agents for many bioactivities such as anti-Alzheimer and... |
| SourceID | pubmedcentral proquest crossref pubmed springer |
| SourceType | Open Access Repository Aggregation Database Index Database Publisher |
| StartPage | 2825 |
| SubjectTerms | Bioavailability Biochemistry Biomedical and Life Sciences Cytotoxicity Life Sciences Organic Chemistry Original Original Article Pharmacy Polymer Sciences |
| SummonAdditionalLinks | – databaseName: SpringerLINK - Czech Republic Consortium dbid: AGYKE link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Na9wwEB3aDYVe0vQzbtKiQm-1gmXJa_sYQtLQ0pwSSE9GkmViurED9obs_o_-344ke5fttofcbDz-kDwavWGengA-50xlKWeMqorHVCBkphnOJFSKSppSVKVxck0_LqbnV-LbdXK9XsftyO5jRdIF6vVaN7shFrXkc2Z1q2j2FHYSuy31BHaOv_78froqHlhY4_KsjFkeBRvWyvz7KZvz0RbI3OZK_lUwdfPQ2Qu4HFfzePrJr6N5r470clvc8TFN3IPdAZeSY-9IL-GJaV7BM79T5QKPHFNUd6_h98mib_v2odbEc0FCYprl4taQurmplWOAhUQ2JZ6Trp6hp5HOkxVJW5GuRcumvTczckE7jFqeqlCSbj6rLEueyNu6RFurGuFFlrEJhIU8FLR9sEoKy3ZGvOytlQwhlk1YvYGrs9PLk3M67O1AtYhETwXXXBkEy0JyxpMyrZiSiWC5lFOrWWnrvQaTZB1JrhRiWlkJLjC8iqzEIKP5W5g0bWP2gWSxmXKdCKUjLXSq81jzEvNehchOsTIO4Mv4h4s7L-FRrMWabZcX2OWF6_IiC-BwdIJiGM5dEWOejNiK5yyAT6vLOBBtdUU2pp2jzRRjYZ4ncRTAO-8zq9dxvDXF5DGAdMObVgZW5HvzSlPfOLFvfKRNwQMIR59Zf9b_W_H-ceYH8Dz2bkcjdggT_IfmA4KtXn0cBtcfycEgkQ priority: 102 providerName: Springer Nature |
| Title | Cytotoxic effect, enzyme inhibition, and in silico studies of some novel N-substituted sulfonyl amides incorporating 1,3,4-oxadiazol structural motif |
| URI | https://link.springer.com/article/10.1007/s11030-022-10422-8 https://www.ncbi.nlm.nih.gov/pubmed/35397086 https://www.proquest.com/docview/2721075391/abstract/ https://search.proquest.com/docview/2648899520 https://pubmed.ncbi.nlm.nih.gov/PMC8994094 |
| Volume | 26 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED9tq5B4QXwTGJWReKNW69hpkidUpo4KRIUQlcpTZDuOFqlLhtKhdf8H_y93cdqqTPCWDyexdefzXe7n3wG8TYVJYikEN4UMuUKXmSe4knCtCu1yVeSupWv6Mh_PFurTMloewWy7F4ZglVub2BrqvLb0j3wYYqiCy5tMxVAb-gtg18P3Vz851Y-iPGtXTOMYeqFQlLDtfZjOv37bZRTI12mDr0QQuEJ0G2j8NjqqtcUJ1y6IEosnh4vUHc_zLoDyryxquzidP4QHnVfJJl4NHsGRqx7DPV9ncoNHLc7TNk_g99lmXa_rm9Iyj-QYMFfdbi4dK6uL0rT4rQHTVY7nrClXqCes8VBDVhesqbFlVf9yKzbnDdocDzTIWXO9KgjjzvRlmWNb4nzwFMnYXyYGcqB4fUM8CLf1innSWiL8YIQFLJ7C4nz6_WzGu8oM3KqRWnMlrTQOXV2lpZBRHhfC6EiJVOsxMU5SttZhiGtHWhqDHqkulFRoHFWSo4mw8hmcVHXlXgBLQjeWNlLGjqyysU1DK3OMWg36ZUbkYQDvtqLIrjwBR7anWibBZSi4rBVclgRwupVW1k3GJturTgBvdrdxGlFuRFeuvsY2Y7RkaRqFowCee-HuPifx0RhDvwDiA7HvGhBF9-GdqrxoqbrxlRRABzDYKsi-W_8excv_j-IV3A-9svKROIUTlJl7ja7R2vThOF7GfehNPv74PO13cwCvLsLJH47CEEU |
| link.rule.ids | 230,315,786,790,891,12083,21416,27957,27958,31754,31755,33779,33780,41116,41558,42185,42627,43345,43840,52146,52269,74102,74659 |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3bbtQwEB3BVoi-IO6EFjASb8Qijp1N8oSgarVAu0KolfoW-RY10jZulS3q9j_4347j7K6WCt4SxblYxx7PZI7PAHwomSpyzhhVNU-pQJeZFriSUClqaY2oje3lmo6m48mJ-H6anQ4_3LqBVrm0ib2hNk77f-SfUgxVcHnjJft8cUl91SifXR1KaNyHLcExVBnB1tf96c9fqzyC93D6kKtgnlLBhm0zYfOcr7BFPZudeSEsWmwuTXf8zbu0yb9yp_2SdPAYHg2-JPkSwH8C92z7FB6E6pILPOrZnbp7Bn_2FnM3d9eNJoG_ERPb3izOLWnas0b1rK2YyNbgOemaGY4O0gWCIXE16Ry2bN1vOyNT2qGlCfQCQ7qrWe2Z7USeNwbbeqWHIIyM30tYzGNB3bVXP7hxMxKkar3MB_EMwPo5nBzsH-9N6FCPgWqRiDkVXHNl0cEVkjOembxmSmaClVKOvc6kz9FaDGx1IrlS6IfKWnCBJlEUBg2D5i9g1LrWvgJSpHbMdSaUTrTQuS5TzQ3Gqgq9McVMGsHHJRTVRZDdqNYCyx64CoGreuCqIoLdJVrVMAW7aj1gIni_uoyTx2dEZGvdFbYZo_0qyyxNIngZwF29juOtOQZ8EeQbsK8aeGHuzSttc9YLdOMjfdgcQbwcIOvP-ncvXv-_F-_g4eT46LA6_Db9sQPbaRi4NGG7MEL87Bt0jubq7TADbgFUjAwU |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCMQF8SyBAkbiRqzGsbNJTggVVuW14kClvUV-RY20jYuyRd3-D_4vM3Z2V0sFt0R2Elsznkf8-RtC3tRcV6XgnOlW5ExCyMwq8CRMyVY5K1vrAl3Tt9nk-ER-nhfzEf80jLDKtU0Mhtp6g__ID3NIVcC9iZoftiMs4vuH6bvznwwrSOFO61hO4ya5BV4yw2oG5XyTfCHVUADbg4dCcAUfD9DEY3RYa4shrp0jJRardp3UtcjzOoDyr13U4Jym98m9Maqk76MaPCA3XP-Q3I51JldwFXCeZnhEfh-tln7pLztDI5Ijpa6_Wp052vWnnQ74rZSq3sI9HboF6AkdItSQ-pYOHnr2_pdb0BkbwOZEoIGlw8WiRYw7VWedhb7I-RApkmG8lKcilcxfIg_ClV_QSFqLhB8UsYDtY3Iy_fjj6JiNlRmYkZlcMimM0A5CXakEF4UtW65VIXmt1AQZJ3G31kGKazIltIaIVLVSSDCOsrJgIox4QvZ637unhFa5mwhTSG0yI01p6twIC1mrhrhMc5sn5O1aFM15JOBotlTLKLgGBNcEwTVVQg7W0mrGxTg0W9VJyOtNMywj3BtRvfMX0GcClqyuizxLyH4U7uZzAh4tIfVLSLkj9k0HpOjebem700DVDa_EBDoh6VpBtsP69yye_X8Wr8gdUP3m66fZl-fkbh71lmX8gOyB-NwLiJKW-mVQ_z9ZZw7a |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cytotoxic+effect%2C+enzyme+inhibition%2C+and+in+silico+studies+of+some+novel+N-substituted+sulfonyl+amides+incorporating+1%2C3%2C4-oxadiazol+structural+motif&rft.jtitle=Molecular+diversity&rft.au=G%C3%BCle%C3%A7%2C+%C3%96zcan&rft.au=T%C3%BCrke%C5%9F%2C+C%C3%BCneyt&rft.au=Arslan%2C+Mustafa&rft.au=Demir%2C+Yeliz&rft.date=2022-10-01&rft.pub=Springer+International+Publishing&rft.issn=1381-1991&rft.eissn=1573-501X&rft.spage=1&rft.epage=21&rft_id=info:doi/10.1007%2Fs11030-022-10422-8&rft_id=info%3Apmid%2F35397086&rft.externalDBID=PMC8994094 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1381-1991&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1381-1991&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1381-1991&client=summon |